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Background: Myc proteins are essential regulators of animal growth during normal development, and their
deregulation is one of the main driving factors of human malignancies. They function as transcription factors that
(in vertebrates) control many growth- and proliferation-associated genes, and in some contexts contribute to global
gene regulation.
Results: We combine chromatin immunoprecipitation-sequencing (ChIPseq) and RNAseq approaches in Drosophila
tissue culture cells to identify a core set of less than 500 Myc target genes, whose salient function resides in the control
of ribosome biogenesis. Among these genes we find the non-coding snoRNA genes as a large novel class of Myc
targets. All assayed snoRNAs are affected by Myc, and many of them are subject to direct transcriptional activation
by Myc, both in Drosophila and in vertebrates. The loss of snoRNAs impairs growth during normal development,
whereas their overexpression increases tumor mass in a model for neuronal tumors.
Conclusions: This work shows that Myc acts as a master regulator of snoRNP biogenesis. In addition, in combination
with recent observations of snoRNA involvement in human cancer, it raises the possibility that Myc’s transforming
effects are partially mediated by this class of non-coding transcripts.
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Growth and proliferation are fundamental for all life. In
metazoans, these processes need to be coordinated with
animal development and homeostasis [1]. One important
factor in the control and coordination of growth is the
Myc family of oncogenes (represented by a single pro-
tein in insects, simply called Myc, and three major para-
logs in vertebrates: c-, N- and L-Myc). Myc’s activity is
essential for normal animal development in insects and
in vertebrates (reviewed in [2,3]). A moderate reduction
of Myc levels in Drosophila results in small cells with
small nucleoli, reduced organismal growth and adult
size, delayed overall development and female sterility
[4,5]. Fruit flies lacking all Myc activity fail to undergo
normal growth and mostly die during early larval stages
[6,7]. Conversely, Myc overexpression in vertebrates
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stated.cellular growth and proliferation [8]. Consistent with
this, mutational activation of Myc, or of upstream sig-
naling pathways, is frequently found in human cancers
and causally contributes to this disease [9]. Knowledge
of the relevant Myc targets, therefore, is essential to
understand the processes of Myc-dependent growth in
normal and pathological situations.
While Myc can control a large number of genes in ver-
tebrates [10-13], the number of Myc targets is still open
in the simpler model Drosophila. Several studies have
characterized Myc-regulated genes [14-16], but they
have not comprehensively addressed which of these
genes are controlled by direct Myc binding, nor have
they included genes that do not code for proteins. How-
ever, recent studies have revealed the abundance and
variety of non-coding transcripts in the eukaryotic gen-
ome, and have emphasized the biological importance of
various such transcripts [17,18]. Some non-coding RNAs
have already been identified as physiologically relevant
Myc targets in vertebrates (rRNAs, tRNAs, miRNAs; seeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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of Myc might be mediated (in part) by these and add-
itional non-protein coding transcripts.
We, therefore, set out to extend the search for Myc
targets to non-polyadenylated transcripts, using a com-
bination of RNAseq and chromatin immunoprecipitation
sequencing (ChIPseq) approaches in cultured Drosophila
cells. This approach led to the identification of a core set
of less than 500 Myc targets. The majority of these targets
control ribosome biogenesis and translation, in good
agreement with earlier reports [8,20,21]. In addition to the
previously identified mRNAs, however, we identified small
nucleolar RNAs (snoRNAs) as a novel class of Myc
targets. The Drosophila genome encodes 288 snoRNAs
(Flybase release FB2014_6; [22]), most of which fall into
one of two classes: the 60 to 100 nucleotides long box
C/D snoRNAs and the 130 to 160 nucleotides long box
H/ACA snoRNAs. Upon association with a small set of
specific proteins, these two types of snoRNAs form
small nucleolar riboproteins (snoRNPs) that catalyze
2’-O-methylation and pseudouridylation, respectively.
Their best characterized targets are small nuclear RNAs
(snRNAs) and ribosomal RNAs, where many of these
post-transcriptional modifications cluster in function-
ally important regions and contribute to efficient ribo-
some biogenesis and/or function. In addition, snoRNAs
have been shown to affect other biological processes, such
as RNA editing, alternative splicing, and gene silencing
(reviewed by [23,24]). Intriguingly, the snoRNA associated
proteins all are encoded by core Myc targets, as are several
of the factors involved in snoRNP processing [8]. These
findings indicate that Myc acts as a master regulator of
snoRNP biogenesis, and they suggest a biological mechan-
ism that ensures the stoichiometry of RNA and protein
components of snoRNPs. At the same time, they reinforce
the notion that snoRNP generation, and hence ribosome
biogenesis, constitutes the core function of Drosophila
Myc. We further provide evidence that vertebrate Myc
also controls snoRNA expression. Finally, we show that
the snoRNA host gene Uhg1 is important for normal
animal growth, and that overexpression of different Uhg
genes enhances tumor growth.
Results
Myc directly binds a core set of sites in Drosophila
In order to establish a core set of genes directly con-
trolled by Myc in Drosophila, we performed ChIPseq
experiments in S2 cells using a mouse monoclonal anti
Drosophila Myc antibody [25]. To control for background
signal, we used non-immune mouse immunoglobulin G
(IgG) in parallel experiments, and we repeated both
anti-Myc and control IgG ChIPs with cells that had
been depleted of Myc. This set of experiments resulted
in the identification of 240 peaks that are specificallybound by Myc in naïve S2 cells but not in Myc-depleted
cells, and that are not recognized by control IgGs
(Figure 1A, Additional file 1: Table S1). Since these
ChIPs relied on a monoclonal antibody, it is conceivable
that some Myc binding sites were missed due to epitope
masking. To exclude this possibility, we conducted
another set of ChIPseq experiments with a rabbit poly-
clonal anti Drosophila Myc antibody [26] and chromatin
from S2 cells, again using species-matched non-immune
IgGs as control. This approach yielded 98 specifically
Myc-bound peaks, most of which (75) overlapped with
the Myc-binding sites identified above (Figure 1B,
Additional file 1: Table S1). Given this coincidence be-
tween the two antibodies, we are confident that we have
identified the majority of Myc bound genes, and (based
on the negative controls) that these genes represent
bona fide Myc-binding sites.
This number of Myc-binding sites is consistent with
what was found in an earlier study that used DamID for
assessing Myc binding [14], but it is considerably lower
than the nearly 4,000 sites that were recently reported for
a ChIPseq study of Drosophila Kc167 cells [27]. Several
possibilities can be considered for this discrepancy. First,
although both Kc167 and S2 cells are hematopoietic cells
of embryonic origin, it is conceivable that they differ in
their molecular characteristics. To address this possibility,
we carried out ChIPseq experiments with rabbit anti-Myc
antibodies and control IgGs using chromatin from Kc167
cells. This led to the identification of 279 Myc-binding
sites (110 of which overlap peaks that were found in S2
cells). However, in these experiments we observed consid-
erably higher background binding than in S2 cells, and,
therefore, only 21 binding sites were statistically significant
(false discovery rate (FDR) <10%), 19 of which overlap
peaks in S2 cells. This similarity with the results in S2
cells argues against major differences between the cell
lines (Figure 1B, Additional file 1: Table S1). Second,
Yang et al. used a different antibody (Santa Cruz rabbit
anti Drosophila Myc) which might have higher affinity
and/or recognize other epitopes on Myc, thus allowing
the identification of additional bona fide Myc-binding
sites. Alternatively, since there are no published data
showing the specificity of this antibody, or of control
ChIPs with non-immune IgG, or control ChIPs from
Myc-depleted cells, some of the 4,000 peaks might also
reflect non-specific binding of the antiserum to chroma-
tin. To address such a possibility, we prepared chromatin
from naïve and from Myc-depleted S2 cells, and con-
ducted ChIP experiments with this commercial antiserum.
As expected, the ChIP signals at the high-affinity Myc
targets nop5 and Uhg1 (see below) are strongly reduced
upon Myc depletion (Additional file 2: Figure S1B). In
contrast, very poor or no reduction is observed at 18
sequences that were identified as Myc binding sites by
Figure 1 (See legend on next page.)
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Figure 1 Myc binding sites in Drosophila. A) Myc binding to the Fibrillarin locus as an example of a binding site in S2 cells. Strong binding is
observed with mouse α-Myc antibodies in naïve S2 cells (1st lane), but not upon Myc depletion (2nd lane) or with control mouse IgG (3rd and 4th
lane); the grey box marks the Myc binding peak as called by the software MACS, the asterisk shows a consensus E-box (‘CACGTG’). Chromosomal
coordinates (on chromosome 2R) are indicated below the traces, as are the extents and orientations of genes in this region. The Western blot
illustrates the efficiency of Myc depletion; the arrowhead points to a band presumably arising from post-translational modification of Myc. Molecular
weight markers (in kD) are indicated. B) Overlaps of Myc binding sites from three different ChIPseq experiments, using either mouse monoclonal or
rabbit polyclonal anti-Myc antibodies, and chromatin from S2 or Kc167 cells. Only peaks called by the software as ‘significant’ were considered, that is,
with false discovery rate (FDR) of <10%. C) Position of Myc binding peaks relative to the nearest transcription start site (TSS). Data are distributed in
100-nt bins for a distance of up to 1,000 nt from the TSS and in 1,000-nt bins for distances between 1,000 and 10,000 nt, and shown as percent of all
265 peaks. Grey bars show all Myc binding peaks, the red line only the Myc binding peaks containing a canonical E-box within a 100 nt window
straddling the Myc binding summit. Horizontal lines above the graph illustrate windows of +/− 100 nt and +/− 1,000 nt around the TSS, containing
58% and 80% of all Myc peaks, and 77% and 93% of the Myc peaks with canonical E-boxes, respectively.
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Figure S1A, B). This non Myc-specific ChIP signal pre-
sumably corresponds to a background reactivity of the
commercial antibody, which is unaffected by the Myc
knock-down even though Myc protein is depleted highly
efficiently (arrow in Additional file 2: Figure S1B). By
inference, we consider it most likely that most of the
sequences that were not identified in our experiments do
not specifically bind to Myc in Drosophila. In our follow-
ing analysis we, therefore, focus on the 265 sites we have
identified in our combined ChIPseq experiments as the
core set of Myc binding sites in Drosophila (all sites that
were specifically bound in at least one experiment in S2
or Kc167 cells, with an FDR <10%; Additional file 1:
Table S1).
Ribosome biogenesis and ribosome protein genes are the
core Myc targets
In a first step, we determined the position of the binding
sites relative to annotated genes. Fifty-eight percent of
all sites map within 100 bp from the nearest transcrip-
tion start site (TSS; grey bars in Figure 1C), and 80% of
the sites are less than 1,000 bp from a TSS, suggesting
that Myc preferentially binds to promoter-proximal se-
quences. This preference is even more striking when
only Myc peaks are considered that cover a canonical
E-box, with 77% of these peaks localizing to within
100 bp of a TSS (red line in Figure 1C). Due to the high
gene density in Drosophila, several Myc binding sites are
located close to more than one TSS, so that altogether 279
genes are potentially affected by Myc binding (see below,
Additional file 1: Table S2).
To determine which of these (or of any other) genes
indeed require Myc for their correct expression we
conducted RNAseq experiments in S2 cells. For this
purpose, we transfected dsRNA directed against Myc (or
GFP as a control) into Drosophila S2 cells and harvested
the cells 24 hours later for total RNA isolation, by which
time Myc protein levels were strongly reduced (Additional
file 2: Figure S2). In order to assess both polyadenylated
and non-adenylated transcripts, we then depleted thesamples of ribosomal RNA and processed the remainder
for deep sequencing. The bioinformatic analysis of
biologically independent triplicates (both for Myc knock-
down and control) resulted in 8,019 genes with detectable
expression in S2 cells and a minimal transcript length of
125 nt. Of these, 281 genes were differentially expressed
upon Myc depletion (see Methods; Additional file 1:
Table S3). The majority of these genes, 240, is downre-
gulated upon Myc depletion. Among these, the poly-
adenylated transcripts show a good overlap with previously
established lists of Myc-activated genes that were obtained
in different settings (Additional file 2: Figure S3A;
[15,16,28]). Note that, in contrast to the Myc-activated
genes, Myc-repressed genes show only poor overlap be-
tween different data sets (Additional file 2: Figure S3B).
Taken together, these observations validate the current
RNAseq data set.
A comparison of the binding and expression data
shows that 139 of the Myc-bound genes are downregu-
lated by at least one third upon Myc-knockdown and 59
are upregulated by at least one third (Additional file 2:
Figure S4A, B). The remaining transcripts were either
not detected in our RNAseq experiments (due to low
expression levels in S2 cells or transcript sizes below the
125 nt cutoff ) or they showed lower responses to altered
Myc levels (some of the corresponding transcripts might
be too stable to show a significant decline over the
course of the experiment). The following analysis focuses
on the 139 genes that are bound by Myc and require
Myc for their full expression and that we, therefore, con-
sider to be the core set of directly Myc-activated genes.
The overwhelming majority of these genes (114, 82%)
functions in ribosome biogenesis and in translation
(Table 1, Additional file 1: Table S4). Myc controls several
steps in this pathway, starting with the synthesis of riboso-
mal RNA by RNA polymerase I (see [8]). Consistent with
earlier reports [28], we did not observe direct binding of
Myc to rRNA loci in our ChIPseq experiments, but Myc
increases the activity of RNA polymerase I by inducing
some of its components or cofactors (for example, RpI135;
Additional file 1: Table S4). Numerous Myc targets then
Table 1 Categories of directly Myc-activated genes
Function Genes
RNA Pol I activity 7
snoRNP function 15
40S subunit assembly, processing, maturation 18
60S subunit assembly, processing, maturation 17
processing of both subunits 3
40S ribosomal subunit 19
60S ribosomal subunit 21
Mitochondrial ribosome 2
Translation factors 6
tRNA processing, maturation 6
Total RiBi and translation 114
Metabolism 5
Transcription, RNA processing 5
Mitochondrial function 4
Other, unknown 11
RiBi, ribosome biogenesis; snoRNP, small nucleolar ribonucleoproteins.
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general (15 genes coding for components of small
nucleolar ribonucleoproteins, RNPs), and the maturation
of the 40S subunit (18 genes) or 60S subunit (17 genes).
Myc further induces the expression of ribosomal pro-
tein genes (19, 21 and 2 genes coding for components
of the small and large ribosomal subunits and the mito-
chondrial ribosome, respectively), of translation factors
(6 genes) and of genes involved in tRNA maturation
(6 genes). Myc has also been reported to promote RNA
polymerase III activity via an interaction with its co-factor
Brf and, therefore, increases the amounts of tRNAs and
other Pol III products [29-31]; because of their small size
these transcripts were not contained in our analysis. We
also did not observe any significant enrichment of Myc at
the 306 annotated tRNA loci in our ChIPseq data (data
not shown). Presumably, Myc does not contact DNA dir-
ectly at these sites; indeed, Myc does not require its DNA
binding domain nor its classical dimerization partner Max
to activate RNA polymerase III [30], and most tRNA loci
(295 of 306) also do not contain any consensus Myc bind-
ing site (E-box; data not shown).
The observation that the majority of Myc-activated
genes controls ribosome biogenesis and translation in-
dicates that these are the main and presumably primor-
dial functions of Myc proteins. At the same time, they
emphasize Myc’s central role for the production (and
to some extent, activity) of ribosomes. Indeed, of 286
genes that were recently identified as essential for
rRNA processing in human cells [32], the homologs of
43 count among these core Myc targets in Drosophila.
The situation is particularly striking for snoRNPs,whose best-characterized activities reside in the post-
transcriptional modifications of rRNAs. All protein
components of snoRNPs are known to be Myc targets,
and our analysis now uncovers a large and novel class
of Myc targets: the non-coding snoRNAs.
A novel class of Myc targets: snoRNA and Uhg genes
After Myc depletion 240 genes are significantly down-
regulated (P <0.05) – and 36 of these do not code for
proteins, but instead for snoRNAs. The Drosophila
genome is predicted to encode 288 snoRNAs ([33] and
FlyBase), ranging in size from 46 to 316 nt. Strikingly, all
of the 103 snoRNAs that pass our 125 nt size cutoff and
are detectably expressed in S2 cells are strongly down-
regulated upon Myc depletion (Figure 2A and Additional
file 1: Table S3). This includes most of the box H/ACA
snoRNAs, but the majority of the box C/D snoRNAs are
smaller than 125 nt and, therefore, not detectable in these
RNAseq experiments. However, qPCR and Northern blot
analysis of several small box C/D snoRNAs confirmed that
they, too, are significantly depleted upon Myc knockdown
(see below), suggesting that Myc affects snoRNA levels in
general. This dramatic impact of Myc on snoRNA levels
can be explained by a combination of different mecha-
nisms. First, most Drosophila snoRNA genes are encoded
in introns of other genes, from which the mature snoR-
NAs are excised [34]. Many of the 84 different host genes
are bona fide Myc targets (Additional file 2: Figure S5),
and Myc’s impact on host gene expression is likely to be
reflected in reduced levels of the intron-encoded snoR-
NAs. Second, snoRNAs function as part of snoRNPs,
whose known protein components all are Myc targets (see
Additional file 1: Table S4 and e.g. [23]). Hence, Myc
downregulation is expected to deplete snoRNPs and, as a
consequence, destabilize the corresponding snoRNAs [35].
Third, Myc also controls the expression of genes that are
dedicated to the synthesis of snoRNAs, the so-called Uhg
genes (‘U-snoRNA host genes’; [33,36]). The following
analysis focuses on Myc’s transcriptional effects on these
Uhg genes.
Seven such genes have been identified in Drosophila,
numbered 1 to 5, 7, 8 (the gene formerly called Uhg6 is
now known as Nop60B); the existence of an additional
Uhg gene is suggested by our data (see below). These
genes do not contain recognizable open reading frames,
and no translation products have been detected (data
not shown; see [37]). Instead, they are dedicated to the
generation of snoRNAs: Uhg genes contain up to 16
introns, each of which codes for a single snoRNA – 48
snoRNAs for the previously described Uhg genes com-
bined (only two introns do not code for any snoRNA). All
of these Uhg (exonic) transcripts are downregulated upon
Myc-depletion in the RNAseq data set. qPCR on biologic-
ally independent samples confirmed this downregulation
Figure 2 (See legend on next page.)
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Figure 2 Effect of altered Myc levels on Uhg and snoRNA expression. A) Gene set enrichment analysis (GSEA) of snoRNAs. The 8,019 detectable
genes are ordered by relative expression (log2 of the ratio of Myc-knockdown over GFP-knockdown) from left to right, and all detectable snoRNAs
are mapped onto these genes (black vertical bars). NES indicates the normalized enrichment score, p the nominal p-value and q the false discovery
rate. B and C) RNA levels were assayed 24 hours after addition of Myc-dsRNA to S2 cells by quantitative PCR (B) and Northern blotting (C); of ten
investigated snoRNAs, five gave no signal or such a weak signal that a reduction in response to Myc-knockdown could not be reliably quantified, four
were clearly reduced upon Myc-knockdown and one was unaffected (see Additional file 1: Table S5). D) qPCR assays carried out six hours after addition
of 125 μM CuSO4 to S2-Myc cells to induce Myc overexpression. Error bars show standard deviations of biologically independent duplicates. Selected
snoRNAs are grouped with the transcripts of their host Uhg genes. Panel C, arrowheads point to mature snoRNAs; the identity of the cross-reactive
slower migrating band in the Me28S-G2703c blot (asterisk) is unclear. The locations of molecular weight DNA markers are indicated. The same RNA
samples were analyzed by reverse transcription and quantitative PCR for the reference genes snm158 and rab6, as well as for the snoRNAs. C’, qPCR
results and quantification of the Northern blot bands. C”, part of each sample that was not used for RNA isolation (shown in panels C and C’)
was analyzed by Western blotting with mouse anti-Myc antibody (top) and mouse anti-α-Tub84B (bottom). The experiment shown in panels C,
C’ and C” is representative of biologically independent duplicates. snoRNA, small nucleolar RNA; Uhg, U-snoRNA host genes.
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NAs are shorter than 125 nucleotides and, therefore, not
contained in our RNAseq data set, we investigated several
of these transcripts by qPCR and found that they were also
downregulated (Figure 2B). Such a downregulation can
also be seen on Northern blots, which further confirms
that the mature snoRNAs are affected by Myc depletion
and not just their immature precursors (Figure 2C shows
three snoRNAs that could be detected in S2 cells; see
legend). Myc is not only required for the full expression
of these Uhg-genes and snoRNAs hosted within their
exons, but transient overexpression of Myc is also suffi-
cient to increase their expression to supraphysiological
levels (Figure 2D). Thus, Myc controls the expression of
many snoRNAs independently of their stability or the
induction of their protein-coding host genes – and it
does so by direct binding to four of the seven Uhg genes.
For Uhg-genes 1, 2 and 5 the Myc peaks are centered on
consensus E-boxes, for Uhg4 the Myc peak is located in
the vicinity of an E-box (Figure 3A, Additional file 2:
Figure S6). In addition, Myc binds to a cluster of three
snoRNA genes on chromosome 2R, that are arranged in
tandem and flanked by a single strongly Myc-bound
consensus E-box (Additional file 2: Figure S6B, labeled
‘2R-cluster’). Since only seven other snoRNA genes are
independently transcribed in Drosophila, we surmise
that this cluster might constitute a novel Uhg locus. The
binding of Myc to Uhg sequences was confirmed by ChIPs
on biologically independent samples (Figure 3B). It
presumably involves Myc:Max complexes (as would be
expected for E-box containing targets), since knock-
down of Myc’s dimerization partner Max reduces Myc
recruitment to these Uhg promoters (data not shown).
To further corroborate Myc’s transcriptional effect on
Uhg genes, we cloned a 983 bp genomic DNA fragment,
comprising the basal promoter and E-box of the Uhg1
locus, in front of firefly luciferase. This Uhg1 promoter
fragment drives strong expression of luciferase upon
transfection into S2 cells. RNA-mediated knockdown of
Myc reduces relative luciferase expression to a similarextent as that of a reporter driven by the promoter of the
previously characterized Myc target CG5033. Conversely,
Myc overexpression significantly increases luciferase
expression (Figure 3C; see [38]). Similar results were
obtained with a luciferase reporter driven by the Uhg5
promoter region (not shown). Note that reporter activ-
ities change more moderately after Myc overexpression
than after knockdown. This suggests that Myc levels in
naïve S2 cells may be sufficiently high to saturate the
Myc binding sites in the reporter plasmids; alternatively,
essential co-factors of Myc may become limiting in con-
ditions of increased Myc expression.
Myc control of snoRNA levels in vertebrates
Taken together, these data demonstrate that Drosophila
Myc directly controls the expression of snoRNAs. To
determine whether this activity of Myc is evolutionarily
conserved, we re-evaluated ChIPseq and RNA expression
data from vertebrate cells. The human genome encodes
745 snoRNAs, 419 of which reside in introns of 232 dif-
ferent host genes [39], including 15 non protein-coding
SNHG loci (‘snoRNA host genes’). To address their regu-
lation by vertebrate Myc, we first examined published data
from human U2OS cells [13]. When all genes were sorted
by the level of Myc binding to their promoters, we ob-
served a significant enrichment for snoRNA host genes
among the highly Myc-bound genes (gene set enrich-
ment analysis in Additional file 2: Figure S7A). Thus, as
was described for genes involved in ribosome biogenesis
and translation [13], snoRNA host genes are bound by
the low physiological levels of c-Myc in U2OS cells.
These genes are also activated by c-Myc, as can be seen
in murine T-cell lymphomas caused by expression of a
tet-controllable Myc transgene [40]. Silencing of the
Myc transgene in this system leads to tumor regression.
This is accompanied by the rapid up- and down-
regulation of 2,287 and 922 genes, respectively, as was
determined by Agilent microarrays [41]. More than 70%
of the latter genes are bound by Myc and, therefore, have
been proposed to correspond to direct transcriptional
Figure 3 Myc directly binds to and controls Uhg promoters. A) ChIPseq profile for the Uhg1 locus in S2 cells. Labeling conventions are as in
Figure 1A. B) ChIP-qPCR of Uhg loci. Chromatin was isolated from naïve S2 cells or from S2 cells depleted of Myc, precipitated with rabbit anti-Myc
(Santa Cruz) or control IgG antibodies and assayed by qPCR for enrichment of the indicated loci. Similar results were obtained with mouse anti-Myc
antibodies (not shown). C) Activity of CG5033- and Uhg1-luciferase reporters in S2 cells upon Myc-overexpression or Myc-knockdown. As a control for
dsRNA against Myc (Myc-kd), dsRNA against GFP was used (ctr-kd); for Myc-overexpression tubulin-GAL4 was co-transfected with UAS-Myc, and control
samples were transfected with tubulin-GAL4 and UAS-T (empty vector). Error bars show standard deviations from six transfections. *P <0.01; **P <0.005
(Student’s two-tailed t-test).
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Myc-activated genes (gene set enrichment analysis in
Additional file 2: Figure S7B). Together with the ChIPseq
data above, this shows that Myc directly controls the ex-
pression of these host genes, and it suggests that Myc also
globally activates the levels of many intronic snoRNAs.
The impact of vertebrate Myc on snoRNA synthesis can
also be observed at the so-called SNHG loci – genes that
are dedicated to the production of snoRNAs, analogouslyto the Drosophila Uhg genes. As an example, the SNHG7
promoter is strongly bound by the low levels of endogen-
ous c-Myc in U2OS cells (Figure 4A, center lane in the
left panel); this association is at least as strong as that
between Myc and its well-established target Nucleolin
([42]; Figure 4A, center lane in the right panel). Induc-
tion of ectopic Myc expression increases the binding to
both SNHG7 and Nucleolin further (Figure 4A; top lanes),
but only slightly augments the expression of these genes
Figure 4 Myc binds to vertebrate non-coding snoRNA host genes (SNHGs). A) ChIPseq traces of SNHG7 (left) and NCL (right; a well characterized,
strongly Myc-bound gene) in human U2OS cells, both shown at the same vertical scale. B) ChIPseq traces of SNHG7 in murine T cells; the expression
level of SNHG7 drops by 4.4-fold after silencing of transgenic Myc expression. C) ChIPseq traces for all 15 SNHG loci in U2OS cells. Each window is 2 kb
wide. Horizontal bars below the input samples denote canonical E-boxes. Samples ‘ectopic Myc’ contain overexpressed Myc, samples ‘-‘ only
endogenous Myc; overexpression of Myc was induced (A; tet-on system) or repressed (B; tet-off system) by the addition of doxycyclin. ChIPseq,
chromatin immunoprecipitation sequencing; snoRNA, small nucleolar RNA.
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are already maximally transactivated by endogenous Myc
[13]. In contrast, in murine T cells expression of endogen-
ous Myc and binding to the Snhg7 promoter are virtually
undetectable (see Figure 4B, center lane). In these cells,
derepression of transgenically expressed Myc triggers
strong association with the Snhg7 promoter, and con-
comitantly induces Snhg7 mRNA expression by 4.4-fold
(Figure 4B, top row). Importantly, Myc is not only re-
cruited to SNHG7, but to the majority of SNHG pro-
moters in murine and human cells, most often to
positions containing canonical E-boxes (Figure 4C anddata not shown; [41]). These data show that the control of
non-coding snoRNA host genes, in particular, and pre-
sumably of snoRNA levels, in general, are an evolutionar-
ily conserved function of Myc proteins.
Uhg-genes promote growth in vivo in Drosophila
To address the importance of snoRNAs for growth, we
focused on the Uhg1 locus since it encodes 16 snoRNAs,
but no other potentially growth-relevant transcripts. Using
imprecise excision of a P-element we generated a null allele
that eliminates the coding regions for all snoRNAs, but
does not affect the neighboring genes (Uhg11; Figure 5A
Figure 5 (See legend on next page.)
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Figure 5 Biological effects of Uhg genes. A) Uhg1 locus with adjacent genes. Black arrows indicate direction of transcription, blue rectangles and
lines correspond to exons and introns, respectively, red triangles show snoRNAs. Below are indicated the genomic regions used for the luciferase
reporter (with the single E-box shown as a vertical line) and the extent of the deletion in the Uhg11 null allele. B) Amino acid incorporation rates in
wandering larvae. Ratios (Uhg11/Uhg1rev) and standard deviations are shown for three biological replicates each with ten larvae for each genotype.
Statistical significance of the difference P = 0.01 (Student’s two-tailed t-test). C) Average time from egg deposition to adult eclosion for male
flies; numbers of analyzed flies are indicated in parentheses. ‘mut’ corresponds to ‘Uhg11’, ‘rev’ to ‘Uhg1rev’, ‘+’ to the standard lab strain ‘y w’. D)
Average area of salivary gland nuclei overexpressing Myc (‘Myc OE’) relative to neighboring nuclei without Myc overexpression (‘ctr’). Each bar
represents 39 to 52 nuclei from 10 separate salivary glands; error bars indicate SEM. E) Luciferase assays from single adult males overexpressing
the indicated Uhg-transgenes under brat-knockdown (brat-kd) or brat-wildtype (ctr) conditions in type II neuroblast lineages. #1 and #2 correspond
to independent transgenes; numbers in parentheses indicate the numbers of individually assayed flies (originating from two to ten separate
experiments). Genotypes: in addition to the indicated UAS-Uhg transgene, the flies carried ‘worniu-GAL4 asense-GAL80/+; UAS-brat-(inverted
repeat) UAS-Luciferase/+’. Difference to control is <0.05 (*) and <0.005 (**), respectively (Student’s two-tailed t-test). SEM, standard error of the
mean; snoRNA, small nucleolar RNA.
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expected to affect 2’-O ribose-methylation of 18S- and
28S-rRNA at five positions that are exclusively targeted
by Uhg1-snoRNAs [43], and as a consequence riboso-
mal assembly and/or activity. Interestingly, 66% of the
resulting Uhg11/Uhg11 mutant females and 50% of the
males survive to adulthood (n = 131 and 99, respect-
ively). These adults are not significantly lighter than
control animals (homozygotes for the wildtype rever-
sion allele Uhg1rev that was obtained by precise excision;
Additional file 2: Figure S8B). Similarly, Uhg11 mutant
wandering larvae contain at least as much protein as
control animals (Additional file 2: Figure S8C). However,
the Uhg11 grow at a significantly slower rate (as inferred
from their rate of incorporating radiolabeled amino acids;
Figure 5B) and accordingly reach corresponding develop-
mental stages later than wild type flies – adult eclosion is
delayed by about 12 hours in Uhg11 mutants (Figure 5C,
Additional file 2: Figure S8D). In addition, Uhg11
females, but not males, show a strongly reduced fertility
(not shown). Both such a developmental delay and
female-specific sterility are typical manifestations of muta-
tions in pathways affecting growth, and they have been ob-
served for hypomorphic mutations in Myc [4]. Consistent
with a contribution of Uhg1 to Myc-dependent growth,
the documented ability of Myc to promote nuclear growth
is blunted in Uhg1 mutant salivary gland cells (Figure 5D;
compare the relative size of Myc-overexpressing nuclei in
wild type versus Uhg1 mutant salivary glands). Together,
these data demonstrate that Uhg1 is required for protein
synthesis and growth. Nevertheless, the complete absence
of Uhg1 has comparatively mild consequences, and in
some tissues Uhg1 seems not to be limiting for growth
and proliferation. We did not observe any impact of the
Uhg11 mutation on the area of imaginal disc cell clones
overexpressing Myc (not shown). Similarly, larval brain
tumors were not obviously influenced by the complete
loss of Uhg1: knockdown of the tumor suppressor brat in
type II neuroblast stem cell lineages leads to tumors that
critically depend on Myc [44]. However, homozygosity forUhg11 in such a setting did not reduce tumor mass, nor
did it prevent the brat knock-down induced reversion of
intermediate progenitor cells to supernumerary neuro-
blasts (not shown). It is possible, though, that the exten-
sion of larval development that is caused by the loss of
Uhg1, masks a potential reduction in tumor growth rate.
As a complementary approach that does not suffer from
confounding effects on developmental timing, we there-
fore investigated the consequences of excessive Uhg levels.
We generated various Uhg transgenes and expressed them
in different settings. Overexpression of Uhg genes on their
own did not increase the size of normal diploid or poly-
ploid cells, nor did this treatment affect the size of cells
co-expressing Myc (data not shown). However, independ-
ent transgenes for Uhg4 and Uhg5 increased the size of
brat-knockdown induced brain tumors, as assayed with a
recently described luciferase-based system (Figure 5E; [5]).
Thus, overexpression of at least two different Uhg-genes
promotes the growth of tumors.
Discussion
In this study, we combine RNAseq and ChIPseq ap-
proaches to identify a core set of direct Myc targets in
Drosophila S2 cells. We find that Drosophila Myc controls
less than 500 genes, substantially fewer than have been
proposed to be controlled by vertebrate Myc [10-13,45].
The overwhelming part of Drosophila Myc targets control
ribosome biogenesis and protein synthesis, which, there-
fore, constitute the core and presumably primordial
function of Myc proteins. Among these core targets we
find an entire novel gene class that has previously not
been recognized as Myc targets: the non protein-coding
snoRNAs. Some of Myc’s effect on snoRNA levels may
be indirect (via the activation of their host genes or by
affecting their stability), but a sizable fraction of snoR-
NAs encoded in Uhg genes is directly transcriptionally
activated by Myc (Figure 6).
snoRNAs mostly fall into either the box H/ACA or
the box C/D class, depending on the structural elements
they contain (reviewed by [23]). Upon binding to specific
Figure 6 Schematic of Myc function in Drosophila. The majority of RNA Polymerase II transcribed direct Myc targets (defined as genes that are
bound and activated by Myc) control ribosome biogenesis (RiBi genes) or code for ribosomal proteins. The area of each group is proportional to
the number of genes it contains; intronic snoRNAs are counted as direct Myc targets if their host genes are direct Myc targets. Previously, Myc
has been shown to activate RNA Polymerases I and III and hence the transcription of rRNAs and tRNAs. Thus, the major function of Drosophila
Myc resides in the control of protein synthesis. snoRNA, small nucleolar RNA.
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(by catalyzing pseudouridylation, methylation and cleav-
age) and contribute to their folding, thereby playing an
important role in ribosome biogenesis. In addition, some
snoRNAs have been shown to regulate alternative splicing
[46], affect RNA editing [47], mediate apoptosis in re-
sponse to lipotoxic stress [48], serve as progenitors of
miRNAs (reviewed by [49]), and they may contribute to
the maintenance of open chromatin structure [50]. Most
animal snoRNAs are encoded in introns of other genes,
many of which code for ribosome- and translation-related
proteins [34]. This arrangement is thought to help adapt
snoRNA production to a cell’s biosynthetic needs. Here,
we identify a new means by which the balanced synthe-
sis of the different components of snoRNP complexes is
achieved. The protein partners of snoRNAs are well
established direct transcriptional targets of Myc, that is,
the box C/D snoRNP components Fibrillarin, Nop56,
Nop58/Nop5, 15.5K/hoi-polloi, and the box H/ACA
snoRNP components GAR1, Dyskerin/Nop60B, NHP2,
NOP10/CG7637. Moreover, several factors required for
snoRNP assembly or localization are direct Myc targets
(for example, Nopp140, U3-55K, DDX18/pitchoune,
DDX51/Dbp73D) or show close genetic and physical
interaction with Myc (Tip48/reptin, Tip49/pontin)
(Additional file 1: Table S4 and reviews by [3,23]). Thus, a
single transcription factor, Myc, controls all componentsthat make up snoRNP particles, as well as several factors
that contribute to their function, thereby acting as a
master regulator of snoRNP production. At the same
time, the production of snoRNPs and rRNA modifica-
tions constitute the core function of Myc, as 48% of its
mostly highly controlled target genes are dedicated to this
task. Our data further show that this control of snoRNA
levels by Myc is biologically relevant. The loss of Uhg1-
encoded snoRNAs impairs normal growth, whereas
overexpression of a subset of Uhg genes promotes tumor
growth in a Myc-dependent brain tumor system.
While our studies have focused on Drosophila, we
also found that Myc’s control of snoRNA host genes is
conserved in vertebrates. Indeed, recent publications
provide support for Myc’s role in snoRNA expression. A
bioinformatic analysis of 131 intergenic human snoRNA
promoters found an enrichment of E-boxes, that is,
potential Myc binding sites [39]. This suggests that, in
addition to intronic snoRNAs (our data), independently
transcribed snoRNAs might be activated by direct Myc
binding. Moreover, several snoRNAs were found to be
significantly overexpressed in neuroblastomas with high-
level N-Myc expression (that is, N-Myc amplification),
as well as in cultured cell lines in response to N-Myc
activation [51]. This observation raises the possibility
that snoRNAs contribute to the growth of N-Myc
dependent tumors, analogously to what we observed
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neuroblast tumors. Several publications point to a
possible role for snoRNA deregulation in other cancers
as well (for reviews see [52,53]). Thus, the levels of
snoRNAs are elevated in non-small-cell lung cancer
(NSCLC), acute leukemias, and metastatic prostate can-
cer [54-56], and individual snoRNAs have been shown
to contribute to cellular proliferation and/or transform-
ation (SNORD114-1 in K562 cells [55], SNORA42 in
breast cancer [57]). On the other hand, certain snoR-
NAs were also shown to have a negative impact on pro-
liferation (snoRNA U50 in prostate cancer [58]), breast
cancer [59], and some tumors display reduced snoRNA
levels (multiple myeloma and secondary plasma cell
leukemia: [60]).
Conclusions
In transformed vertebrate cells, the oncogene Myc is
thought to act as a general transcriptional amplifier. In
contrast, our present study shows that at physiological
levels in Drosophila cells, Myc directly binds and con-
trols only a limited number of transcriptional targets –
less than 500. In addition to previously described Myc
targets that contribute to ribosome biogenesis and pro-
tein translation, we find that Myc controls the levels of
all snoRNAs. Most of these small RNAs function as part
of ribonucleoproteins to post-transcriptionally modify
rRNAs, which then presumably affects ribosome activity.
Indeed, several observations in vertebrate tumors (as
well as our experiments in Drosophila) suggest a correl-
ation between the levels of certain snoRNAs and the rate
of normal and/or pathological growth. It remains to be
seen whether this reflects a global alteration of protein
synthesis or differential effects on specific proteins. The
accessibility of the Drosophila system, both for loss-of-
function and overexpression approaches, raises the possibil-
ity of experimentally addressing these issues in the future. In
short, our data highlight the non-coding snoRNAs as a novel
and evolutionarily conserved class of direct Myc targets that
are likely to play an important role both in normal develop-
ment, as well as in Myc-dependent pathological growth.
Methods
Generation of mutant flies, transgenes and reporters
The allele Uhg11 (null mutant) and Uhg1rev (wild type re-
vertant) were generated by mobilization of P{w[+mC] =
EP}Uhg1[G11659] (Bloomington Stock Center number
B-28084, Indiana University; Bloomington, IN, USA),
inserted after position chr2R:13’586’605 (coordinates
throughout refer to genome release 5) in Uhg1 exon 1.
Uhg11 carries a deletion of nucleotides chr2R:13’586’606 to
13’590’803 (first to last exon of Uhg1).
UAS-Uhg transgenes were generated in a ‘y w’ back-
ground by cloning appropriate PCR fragments (Additionalfile 1: Table S5) into pUAS-T, followed by sequence
verification and standard transgenesis procedures.
Additional flies: wor-GAL4 ase-GAL80/CyO; UAS-
brat-IR UAS-FLuc/TM3, Sb Ser tubulin-GAL80[ts] [5],
actin-FRT-CD2-FRT-GAL4 hs-FLP (H.Stocker, ETH
Zürich, Switzerland), UAS-vito::GFP [61] (Bloomington
Stock Center).
In vivo analysis
To measure the time from egg deposition to adult eclo-
sion, timed egg lays (5 to 14 hours) were performed in
10 to 50 culture vials per genotype (‘y w; Uhg11/CyO, y + ’,
‘y w; Uhg1rev’, ‘y w’, ‘y w; Uhg11/CyO,y+’ x ‘y w’), so as to
avoid overcrowding. Eclosion was monitored two to three
times a day. Developmental times were combined using a
weighted 10-hour floating window (perl script available
upon request).
For weighing flies, one to four day old flies were dried
for 20 minutes at 95° (first for 10 minutes with a closed,
then with an opened lid) and then stored at room
temperature. Before weighing on a Mettler UMT5
Comparator scale (Mettler Toledo, Giessen, Germany),
the flies were allowed to equilibrate with ambient atmos-
phere for at least 30 minutes.
For clonal overexpression of Myc, the genotypes ‘y w
actin-FRT-CD2-FRT-GAL4 hs-FLP/y w; Uhg11/Uhg11;
UAS-vito::GFP/UAS-Myc UAS-GFP’ and ‘y w actin-FRT-
CD2-FRT-GAL4 hs-FLP/y w; (Sp or CyO,y+)/+; UAS-
vito::GFP/UAS-Myc UAS-GFP’ were analyzed. At two to
three days of development, clones were induced by an
8- to 15-minute incubation in a 37° water bath; 48 hours
later, wandering larvae were collected, fixed for 20
minutes at room temperature in 4% paraformaldehyde/PBS
containing 0.1% Tween-20, stained with 10 μg/ml Hoechst
33258 (Sigma Aldrich, St. Louis, MO, USA) and 2 u/μl Alexa
Fluor 546 Phalloidin (Molecular Probes, Life technologies;
Carlsbad, CA, USA), and destained with PBS-Tween before
mounting in Vectashield Mounting Medium (Biozol
Diagnostica, Eching, Germany). Images were recorded on a
Nikon Eclipse Ti-E confocal microscope, using a 20 × lens.
To determine protein translation activity in wandering
larvae, 750 μl Ringer’s solution containing 15 μCi/ml
3H-labeled amino acid mix (Hartmann Analytic, Braun-
schweig, Germany) were added to 10 fully inverted larvae
and placed on a rotating wheel for one hour at room
temperature. The supernatant was then decanted and the
carcasses were washed twice with cold Ringer’s solution
before they were crushed in 350 μl cell lysis buffer
(100 mM Tris-Cl (pH 8.0), 100 mM NaCl, 0.5% Triton X-
100) with a pestle. Samples were incubated for 10 minutes
on ice with periodic vortexing, followed by a 2 minute
centrifugation. A total of 250 μl of the aqueous lysate was
mixed with 15 μl suspended Strataclean Resin (Stratagene,
Agilent Technologies; Santa Clara, CA, USA) and allowed
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resins were washed with Ringer’s solution and transferred
to 3 ml scintillation buffer, rested for 30 minutes, and then
counted for 1 minute per vial. The remaining aqueous lys-
ate was processed for protein quantification [62].
Type II neuroblast tumors were induced by knocking
down the tumor suppressor brat specifically in these cells
with the driver system ‘worniu-GAL4 asense-GAL80.’ Co-
expression of firefly luciferase allowed the quantitative de-
termination of tumor mass [5]. Appropriate male adults
(at most 12 hours old) were collected and frozen at −80°
until use. Upon thawing, individual flies were lysed in Passive
Lysis Buffer (Dual Luciferase Reporter Assay System; Pro-
mega, Madison, WI, USA) in a Bullet Blender homogenizer
(Next Advance, Averill Park, NY, USA) and processed for
luminometry in a Glomax luminometer (Promega).
Cell culture and RNA interference
Drosophila S2 and Kc167 cells were cultivated at 25°C in
Schneider’s Insect Medium (Sigma) including 10% fetal
bovine serum (Pan™ Biotech) and 1% penicillin/strepto-
mycin (Sigma). For RNAi experiments, cells were plated
out and washed once in serum free medium. dsRNA
against Myc, or GFP for control, was added directly to
the cells kept in 1/3 volume of serum free medium.
After 30 minutes 2/3 volume of full medium was added.
A total of 2 μg of dsRNA were added per 106 cells. Cells
were harvested 24 hours after RNA addition.
Western blotting
S2 cells were lysed in lysis buffer (150 mM NaCl,
50 mM Tris (pH 8.0), 5 mM ethylenediaminetetraacetic
acid (EDTA) (pH 8.0), 1% Nonidet-P40), mixed with an
equal amount of Laemmli buffer (containing 20% β −
mercaptoethanol) and an extract from 1.25 × 106 cells
was separated on a 10% SDS-PAGE. Proteins were trans-
ferred to a nitrocellulose membrane and incubated with
appropriate antibodies (mouse anti-Myc (described in
[25]), rabbit anti-Myc [26], rabbit anti-Myc (Santa Cruz,
Dallas, TX, USA), mouse anti-α-Tubulin (Sigma)).
RNAseq
Total RNA was isolated from Drosophila S2 cells using
Trizol (Invitrogen, Life Technologies; Carlsbad, CA, USA)
and purified with miRNeasy (Qiagen, Venlo, Netherlands),
followed by on-column DNase treatment to eliminate gen-
omic DNA, all according to the manufacturer’s instructions.
Samples were treated once with RiboMinus™ (Life Technolo-
gies, Carlsbad, CA, USA) to selectively deplete ribosomal
RNA (rRNA). Sequencing libraries were prepared with the
NEBnext® mRNA Library Prep Master Mix set for Illumina
(E6100S/L) following the instruction manual. Briefly,
ribominus-treated RNA was fragmented, first and second
cDNA strands were synthesized, and the resulting duplexwas end-repaired, ligated to NEBnext adaptors and gel puri-
fied with the Qiagen gel extraction kit selecting 200 bp frag-
ments. cDNA was then amplified with 15 cycles of PCR and
the resulting library was subjected to Illumina GAIIx sequen-
cing. For both Myc-knockdown (experimental) and GFP-
knockdown (control) samples, three biologically independent
replicates were prepared and analyzed. Quality and quantity
of RNAs and resulting cDNAs were assessed at several steps
of the procedure through an Experion™ Automated
Electrophoresis System (Bio-Rad, Hercules, CA, USA).
Sequence data were processed through the bioinformatics
pipeline OLB_v1.9, then through a Perl script to eliminate
reads with perfect matches to Drosophila rRNA. The non-
rRNA reads were mapped to the Drosophila genome release
5 with bowtie-0.12.7. (between 2,082,423 and 14,466,659
mapped reads per condition and repeat), converted from sam
to bam format with SAMtools, and statistically analyzed with
the BioconductoR work package. For subsequent analysis we
normalized the total read number from each RNAseq experi-
ment to 1,000,000. Only genes with ≥10 reads combined in
all six samples and with predicted transcript sizes ≥ 125 nt
were kept for final analysis (for a total of 8,019 genes). RNA-
seq and ChIPseq data are available in the ArrayExpress data-
base [63] under accession number E-MTAB-3209.
ChIPseq
For chromatin immunoprecipitation (ChIP), cells were cross-
linked with 1% formaldehyde at 37°C for 10 minutes and the
reaction was stopped with 50 mM glycine. Cells were lysed
and nuclei were resuspended in radioimmunoprecipitation
assay (RIPA) buffer. Sonication with a Branson sonifier was
carried out until the majority of fragments showed nucleo-
somal size. Cells were immunoprecipitated with Myc anti-
body (mouse α-Myc, rabbit α-Myc, Santa Cruz rabbit α-Myc)
or control IgG from mouse or rabbit (Sigma) which were
coupled to Protein A/G-dynabeads (Invitrogen). DNA was
purified with phenol-chloroform after elution of the bound
chromatin with 1% SDS and reversion of the crosslink.
ChIP DNA was end repaired and A tailed. Illumina
adaptors were ligated to the ChIP DNA fragments. Frac-
tions with a size of 175 to 225 bp were cut out from a
2% agarose gel, extracted by Qiagen gel extraction kit
and enriched by 18 cycles of PCR amplification. The
library-size was controlled with the Experion-system
(BioRad) and quantified using a picogreen assay. The
library was sequenced on a Illumna GAIIx sequencer.
Sequence data were processed with OLB_v1.9 and
mapped to the Drosophila genome release 5 with
bowtie-0.12.7. For each condition, we obtained between
12,569,801 and 33,927,814 reads, for which between 47%
and 75% aligned to a single position in the Drosophila
genome and were further considered, 2% to 31% did not
align anywhere, and the remainder showed multiple
alignments (corresponding typically to transposons and
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MACS14, using the same number of reads with single
alignment for all conditions (6,874,000) and the default
settings (with the switch ‘-g dm’). Number of called
peaks for the different conditions: 260 and 27 (mouse α-
Myc and non-immune mouse IgG in naïve S2 cells), 22
and 24 (mouse α-Myc and non-immune mouse IgG in
Myc-depleted S2 cells), 263 and 31 (rabbit α-Myc and
non-immune rabbit IgG in S2 cells), 308 and 187 (rabbit
α-Myc and non-immune rabbit IgG in Kc167 cells).
Subsequently, we eliminated from the Myc-ChIP lists
all unmapped peaks (mostly assigned to chromosome
‘Uextra’; 3 to 17 peaks per condition) and all peaks that
were called in any of the ChIPs with non-immune IgGs
or in Myc-ChIPs from Myc-depleted S2 cells, resulting in
240 (mouse α-Myc in S2 cells; 240 with FDR < 10%), 243
(rabbit α-Myc in S2 cells; 98 with FDR <10%), 279
peaks (rabbit α-Myc in Kc167 cells; 21 with FDR < 10%).
Additional file 1: Table S1 lists all 265 peaks that are
significant (FDR <10%) in at least one condition, and
includes non-significant peaks (FDR ≥10%) if they over-
lap a significant peak.
qPCR of S2 cells
For ‘standard’ qPCR, total RNA was isolated from Myc
and control depleted Drosophila S2 cells as described for
RNAseq. The miScript II RT Kit (Qiagen) was used to
generate cDNA which allows the conversion of all RNA
species. cDNA was analyzed as described for ChIP DNA,
using the ΔΔCT method for evaluation of the results.
Every qRT-PCR was performed in triplicate for at least
two biologically independent samples. The averages of two
or three of the reference genes rab6, snm158 and α-
Tubulin were set to 100%, since these genes were found to
be unaffected by Myc-knockdown in our RNAseq, as well
as earlier experiments.
Northern blot
Total RNA was extracted from Drosophila S2 cells as
described above. A total of 20 μg RNA was loaded per lane
on a 10% acrylamide 8 M urea gel and then transferred to
a Hybond N+ nylon membrane (GE Healthcare, Chalfont
St Giles, Great Britain (Frankfurt)). After UV crosslinking
at 254 nm the membrane was pre-hybridized in 10 ml
Church buffer (1 mM EDTA pH 8.0, 0.17% phosphoric
acid, 0.5 M Na2HPO4, 7% SDS) for one hour at 62°C.
DNA oligonucleotide probes were 5′ end-labeled with
γ-32P-ATP using T4 polynucleotide kinase (NEB) and hy-
bridized overnight in Church buffer at 62°C. The blots
were washed in 2 × SSC (300 mM NaCl, 30 mM sodium
citrate) and 0.2 × SSC for 30 minutes at 62°C, dried, ex-
posed and developed on a Typhoon 9200 phosphorimager
(GE healthcare). Quantification was performed using
ImageJ software.Uhg1 reporter analysis
A 983 bp genomic fragment (chr2R: 13,585,896 to chr2R:
13,586,878) encompassing the TSS of Uhg1 (chr2R:13,
586,602) and the E-box at chr2R:13,586,588 was cloned in
front of the firefly luciferase coding sequence and the
SV40 polyadenylation signal, yielding pGL-Uhg1WT. For
luciferase assays, 1.3 × 106 S2 cells were plated into each
well of a 24-well plate and transfected with 0.2 μg of
reporter plasmid (pGL-Uhg1WT or pGL-CG5033WT)
and 200 ng of reference plasmid pRL-CG5033ΔE, using
Effectene (Qiagen) according to the manufacturer’s in-
structions (for CG5033-plasmids, dsRNA and assay proto-
col, see [38]). Where indicated, 30 ng of dsRNA against
Myc or GFP, or 200 ng pTub-GAL4 plus 200 ng pUAS-
Myc or pUAS-T, were included in the transfection mix.
One day after the transfection, cells were harvested, lysed
and firefly and Renilla luciferase activities were measured
using the Dual Luciferase Assay System (Promega) in a
Glomax luminometer. Each experiment was carried out at
least twice (on separate days), and every transfection
within each experiment was done in triplicate.
Further bioinformatic analysis
To calculate distances of the 265 peaks to the nearest
transcription start sites (TSS) we used closestBed from the
Bedtools suite v.2.17.0. and the Drosophila genome anno-
tation FlyBase fb_2013_05. To assign genes to mapped
ChIP peaks, we used intersectBed and closestBed and sub-
sequently manually pruned the gene lists. For ChIPseq
peaks overlapping at least one gene with statistically sig-
nificant expression change upon Myc depletion (P < 0.05),
only transcriptionally affected genes were retained. When
a peak mapped within 100 bp of the TSS of a transcrip-
tionally unaffected gene, other transcriptionally unaffected
genes with TSS at more than 300 bp distance from the
peak were eliminated (20 instances). For intronic snoR-
NAs, only the host genes were retained.
For the analysis of peaks from Yang et al. [27] we used
the data published by these authors and the program
intersectBed (bedtools v.2.17.0.) to determine the ratio of
mouse α-Myc ChIPseq reads from naïve S2 cells versus
Myc-depleted S2 cells for each of the 3,993 peaks. In total,
1,936 regions with a ratio ‘naïve/Myc-depleted’ ≤ 1.2 that
did not overlap any of our peaks were retained and sorted
by the number of reads that were recorded by Yang et al.
From this sorted list we selected every 50th peak (for a
total of 20 peaks), starting with the region with the highest
number of reads in the Yang analysis, and designed
primers covering the summit coordinate indicated by Yang
et al. (one region was omitted since no acceptable primers
could be generated, and two primer pairs did not function,
that is, did not produce the expected product).
For GO term analysis we used the online resource
GOrilla [64] and all Drosophila genes according to FlyBase
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cation of binding sites was carried out with the online
resource MEME-ChIP [65]. Gene Set Enrichment Analysis
was performed with the GSEA software [66]. ChIPseq
reads were visualized with the IGB browser [67]. Venn
diagrams were drawn with the help of eulerAPE v.1.0 [68].
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experimental approaches. Figure S4. Effect of Myc-depletion on the
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